318 related articles for article (PubMed ID: 18413738)
1. MUC1 expression is regulated by DNA methylation and histone H3 lysine 9 modification in cancer cells.
Yamada N; Nishida Y; Tsutsumida H; Hamada T; Goto M; Higashi M; Nomoto M; Yonezawa S
Cancer Res; 2008 Apr; 68(8):2708-16. PubMed ID: 18413738
[TBL] [Abstract][Full Text] [Related]
2. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors.
Kikuchi T; Toyota M; Itoh F; Suzuki H; Obata T; Yamamoto H; Kakiuchi H; Kusano M; Issa JP; Tokino T; Imai K
Oncogene; 2002 Apr; 21(17):2741-9. PubMed ID: 11965547
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
[TBL] [Abstract][Full Text] [Related]
5. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T
Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390
[TBL] [Abstract][Full Text] [Related]
6. MUC2 expression is regulated by histone H3 modification and DNA methylation in pancreatic cancer.
Yamada N; Hamada T; Goto M; Tsutsumida H; Higashi M; Nomoto M; Yonezawa S
Int J Cancer; 2006 Oct; 119(8):1850-7. PubMed ID: 16721789
[TBL] [Abstract][Full Text] [Related]
7. Methylation adjacent to negatively regulating AP-1 site reactivates TrkA gene expression during cancer progression.
Fujimoto M; Kitazawa R; Maeda S; Kitazawa S
Oncogene; 2005 Jul; 24(32):5108-18. PubMed ID: 15870692
[TBL] [Abstract][Full Text] [Related]
8. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
9. Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme activity.
Guarcello V; Blanquicett C; Naguib FN; El Kouni MH
Cancer Chemother Pharmacol; 2008 Jun; 62(1):85-96. PubMed ID: 17805539
[TBL] [Abstract][Full Text] [Related]
10. Expression of MUC5AC, an early marker of pancreatobiliary cancer, is regulated by DNA methylation in the distal promoter region in cancer cells.
Yamada N; Nishida Y; Yokoyama S; Tsutsumida H; Houjou I; Kitamoto S; Goto M; Higashi M; Yonezawa S
J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):844-54. PubMed ID: 20734208
[TBL] [Abstract][Full Text] [Related]
11. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
Zaretsky JZ; Barnea I; Aylon Y; Gorivodsky M; Wreschner DH; Keydar I
Mol Cancer; 2006 Nov; 5():57. PubMed ID: 17083744
[TBL] [Abstract][Full Text] [Related]
12. Histone methylation at gene promoters is associated with developmental regulation and region-specific expression of ionotropic and metabotropic glutamate receptors in human brain.
Stadler F; Kolb G; Rubusch L; Baker SP; Jones EG; Akbarian S
J Neurochem; 2005 Jul; 94(2):324-36. PubMed ID: 15998284
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation and histone modification regulate silencing of OPG during tumor progression.
Lu TY; Kao CF; Lin CT; Huang DY; Chiu CY; Huang YS; Wu HC
J Cell Biochem; 2009 Sep; 108(1):315-25. PubMed ID: 19565568
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of the human mucin gene MUC4 in epithelial cancer cell lines involves both DNA methylation and histone modifications mediated by DNA methyltransferases and histone deacetylases.
Vincent A; Ducourouble MP; Van Seuningen I
FASEB J; 2008 Aug; 22(8):3035-45. PubMed ID: 18492726
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma.
Yamamura N; Kishimoto T
Exp Mol Pathol; 2012 Aug; 93(1):35-9. PubMed ID: 22472323
[TBL] [Abstract][Full Text] [Related]
16. Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.
Hinshelwood RA; Huschtscha LI; Melki J; Stirzaker C; Abdipranoto A; Vissel B; Ravasi T; Wells CA; Hume DA; Reddel RR; Clark SJ
Cancer Res; 2007 Dec; 67(24):11517-27. PubMed ID: 18089780
[TBL] [Abstract][Full Text] [Related]
17. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation.
Tang H; Goldberg E
J Androl; 2009; 30(2):157-67. PubMed ID: 18930904
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells.
Zhang Z; Joh K; Yatsuki H; Zhao W; Soejima H; Higashimoto K; Noguchi M; Yokoyama M; Iwasaka T; Mukai T
Cancer Lett; 2007 Mar; 247(2):318-27. PubMed ID: 16806674
[TBL] [Abstract][Full Text] [Related]
19. Histone methylation is a critical regulator of the abnormal expression of POU5F1 and RASSF1A in testis cancer cell lines.
Lambrot R; Kimmins S
Int J Androl; 2011 Apr; 34(2):110-23. PubMed ID: 20497257
[TBL] [Abstract][Full Text] [Related]
20. [DNA methylation and histone modification relate to RASSF1A gene deletion in laryngeal carcinoma tissues].
Yang J; Ji WY; Qu YR; He LX; Zhao XD; Jin MZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Apr; 46(4):308-12. PubMed ID: 21624251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
